30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Nuvalent Inc (NUVL)

Track

Over the last 90 days, Nuvalent Inc. has seen significant insider selling, with a total sell value exceeding $50 million. Notably, executives like the President and CEO, James Richard Porter, and Chief Development Officer, Darlene Noci, have engaged in multiple planned and proposed sales. This activity occurred despite a positive 90-day stock price change of 28.0%.
Stock chart
Ticker: NUVL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Noci Darlene
Chief Development Officer
2 sales — total 200,000 USD
Planned sale 9 Jun 2026
Value US$1,207,161.18 | Price 422.64 | Shares 71,053
Planned sale 9 Jun 2026
Value US$923,487.10 | Price 338.26 | Shares 54,259
Proposed sale 9 Jun 2026
Value US$1,954,448.14 | Price 88.18 | Shares 97,802
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 89.63 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 88.79 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 87.97 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 89.63 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 88.79 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 87.97 | Shares 1,000
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 90.48 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 103.84 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 101.79 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 100.65 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 99.86 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 98.57 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 97.68 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 95.99 | Shares 1,000
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 94.87 | Shares 1,000
Planned sale 28 May 2026
Value US$182,421.70 | Price 109.30 | Shares 1,669
Planned sale 28 May 2026
Value US$97,326.00 | Price 108.14 | Shares 900
Planned sale 28 May 2026
Value US$164,398.50 | Price 107.45 | Shares 1,530
Planned sale 28 May 2026
Value US$148,954.32 | Price 106.32 | Shares 1,401
Planned sale 28 May 2026
Value US$148,954.32 | Price 106.32 | Shares 1,401
Planned sale 28 May 2026
Value US$10,976.00 | Price 109.76 | Shares 100
Planned sale 28 May 2026
Value US$10,976.00 | Price 109.76 | Shares 100
Planned sale 28 May 2026
Value US$163,950.00 | Price 109.30 | Shares 1,500
Planned sale 28 May 2026
Value US$163,950.00 | Price 109.30 | Shares 1,500
Planned sale 28 May 2026
Value US$127,235.78 | Price 108.01 | Shares 1,178
Planned sale 28 May 2026
Value US$127,235.78 | Price 108.01 | Shares 1,178
Planned sale 28 May 2026
Value US$152,623.26 | Price 107.33 | Shares 1,422
Planned sale 28 May 2026
Value US$152,623.26 | Price 107.33 | Shares 1,422
Planned sale 28 May 2026
Value US$138,138.00 | Price 106.26 | Shares 1,300
Planned sale 28 May 2026
Value US$138,138.00 | Price 106.26 | Shares 1,300
Planned sale 4 May 2026
Value US$217,179.68 | Price 102.88 | Shares 2,111
Planned sale 4 May 2026
Value US$1,771,741.30 | Price 102.10 | Shares 17,353
Planned sale 4 May 2026
Value US$753,894.92 | Price 101.48 | Shares 7,429
Planned sale 4 May 2026
Value US$140,476.16 | Price 99.77 | Shares 1,408
Planned sale 4 May 2026
Value US$167,419.46 | Price 98.54 | Shares 1,699
Planned sale 1 May 2026
Value US$12,396.28 | Price 99.97 | Shares 124
Planned sale 1 May 2026
Value US$738,121.86 | Price 99.29 | Shares 7,434
Planned sale 1 May 2026
Value US$381,082.24 | Price 98.42 | Shares 3,872
Planned sale 30 Apr 2026
Value US$107,734.74 | Price 99.57 | Shares 1,082
Planned sale 30 Apr 2026
Value US$437,956.34 | Price 99.13 | Shares 4,418
Proposed sale 30 Apr 2026
Value US$1,635,150.00 | Price 99.10 | Shares 16,500
Planned sale 29 Apr 2026
Value US$30,351.00 | Price 101.17 | Shares 300
Planned sale 29 Apr 2026
Value US$70,098.00 | Price 100.14 | Shares 700
Planned sale 29 Apr 2026
Value US$447,075.00 | Price 99.35 | Shares 4,500
Planned sale 9 Apr 2026
Value US$94,500.00 | Price 105.00 | Shares 900
Planned sale 9 Apr 2026
Value US$228,664.11 | Price 104.27 | Shares 2,193
Planned sale 6 Apr 2026
Value US$10,560.00 | Price 105.60 | Shares 100
Planned sale 6 Apr 2026
Value US$641,358.38 | Price 104.78 | Shares 6,121
Planned sale 6 Apr 2026
Value US$1,289,466.50 | Price 103.78 | Shares 12,425
Planned sale 6 Apr 2026
Value US$1,171,846.34 | Price 103.21 | Shares 11,354
Planned sale 1 Apr 2026
Value US$262,158.42 | Price 106.18 | Shares 2,469
Planned sale 1 Apr 2026
Value US$570,410.10 | Price 105.30 | Shares 5,417
Planned sale 1 Apr 2026
Value US$369,958.16 | Price 104.39 | Shares 3,544
Planned sale 30 Mar 2026
Value US$291,249.84 | Price 98.13 | Shares 2,968
Planned sale 30 Mar 2026
Value US$246,692.76 | Price 97.43 | Shares 2,532
Proposed sale 30 Mar 2026
Value US$2,126,520.00 | Price 96.66 | Shares 22,000
Planned sale 26 Mar 2026
Value US$278,786.38 | Price 99.46 | Shares 2,803
Planned sale 26 Mar 2026
Value US$172,554.97 | Price 98.21 | Shares 1,757
Planned sale 26 Mar 2026
Value US$91,650.00 | Price 97.50 | Shares 940
Planned sale 25 Mar 2026
Value US$1,372,192.00 | Price 100.16 | Shares 13,700
Planned sale 24 Mar 2026
Value US$111,940.00 | Price 96.50 | Shares 1,160
Planned sale 24 Mar 2026
Value US$735,495.48 | Price 95.88 | Shares 7,671
Planned sale 24 Mar 2026
Value US$246,982.97 | Price 95.03 | Shares 2,599
Proposed sale 24 Mar 2026
Value US$5,729,870.00 | Price 96.43 | Shares 59,420
Planned sale 13 Mar 2026
Value US$169,806.13 | Price 99.71 | Shares 1,703
Planned sale 13 Mar 2026
Value US$256,661.51 | Price 98.83 | Shares 2,597
Planned sale 13 Mar 2026
Value US$78,703.56 | Price 97.89 | Shares 804
Planned sale 12 Mar 2026
Value US$30,330.72 | Price 99.12 | Shares 306
Planned sale 12 Mar 2026
Value US$541,912.20 | Price 98.44 | Shares 5,505
Planned sale 12 Mar 2026
Value US$2,365,442.31 | Price 97.79 | Shares 24,189
Proposed sale 12 Mar 2026
Value US$3,821,609.85 | Price 100.05 | Shares 38,197
Planned sale 6 Mar 2026
Value US$40,076.00 | Price 100.19 | Shares 400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-09 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
71,053 +41.0%
422.64
US$1,207,161 		71,053 +41.0% 422.64 US$1,207,161
2026-06-11 2026-06-09 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
54,259 +7.7%
338.26
US$923,487 		54,259 +7.7% 338.26 US$923,487
2026-06-09 2026-06-09 PrS Proposed sale
2.3
Darlene Noci

Officer

Officer
97,802
88.18
US$1,954,448 		97,802 88.18 US$1,954,448
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -0.9%
89.63
US$100,000 		1,000 -0.9% 89.63 US$100,000
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -4.2%
88.79
US$100,000 		1,000 -4.2% 88.79 US$100,000
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -3.5%
87.97
US$100,000 		1,000 -3.5% 87.97 US$100,000
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -0.9%
89.63
US$100,000 		1,000 -0.9% 89.63 US$100,000
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -4.2%
88.79
US$100,000 		1,000 -4.2% 88.79 US$100,000
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,000 -3.5%
87.97
US$100,000 		1,000 -3.5% 87.97 US$100,000
2026-06-08 2026-06-08 PrS Proposed sale
James Richard Porter

Officer

Officer
1,000
90.48
US$100,000 		1,000 90.48 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -0.2%
103.84
US$100,000 		1,000 -0.2% 103.84 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -0.3%
101.79
US$100,000 		1,000 -0.3% 101.79 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -2.9%
100.65
US$100,000 		1,000 -2.9% 100.65 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -3.4%
99.86
US$100,000 		1,000 -3.4% 99.86 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -1.3%
98.57
US$100,000 		1,000 -1.3% 98.57 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -1.0%
97.68
US$100,000 		1,000 -1.0% 97.68 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -2.3%
95.99
US$100,000 		1,000 -2.3% 95.99 US$100,000
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,000 -1.0%
94.87
US$100,000 		1,000 -1.0% 94.87 US$100,000
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,669 -2.7%
109.30
US$182,422 		1,669 -2.7% 109.30 US$182,422
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
900 -1.4%
108.14
US$97,326 		900 -1.4% 108.14 US$97,326
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,530 -2.4%
107.45
US$164,398 		1,530 -2.4% 107.45 US$164,398
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,401 -2.2%
106.32
US$148,954 		1,401 -2.2% 106.32 US$148,954
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,401 -2.2%
106.32
US$148,954 		1,401 -2.2% 106.32 US$148,954
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
100 -0.2%
109.76
US$10,976 		100 -0.2% 109.76 US$10,976
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
100 -0.2%
109.76
US$10,976 		100 -0.2% 109.76 US$10,976
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,500 -2.5%
109.30
US$163,950 		1,500 -2.5% 109.30 US$163,950
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,500 -2.5%
109.30
US$163,950 		1,500 -2.5% 109.30 US$163,950
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,178 -1.9%
108.01
US$127,236 		1,178 -1.9% 108.01 US$127,236
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,178 -1.9%
108.01
US$127,236 		1,178 -1.9% 108.01 US$127,236
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,422 -2.3%
107.33
US$152,623 		1,422 -2.3% 107.33 US$152,623
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,422 -2.3%
107.33
US$152,623 		1,422 -2.3% 107.33 US$152,623
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,300 -2.0%
106.26
US$138,138 		1,300 -2.0% 106.26 US$138,138
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,300 -2.0%
106.26
US$138,138 		1,300 -2.0% 106.26 US$138,138
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
2,111 -0.6%
102.88
US$217,180 		2,111 -0.6% 102.88 US$217,180
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
17,353 -5.0%
102.10
US$1,771,741 		17,353 -5.0% 102.10 US$1,771,741
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
7,429 -2.1%
101.48
US$753,895 		7,429 -2.1% 101.48 US$753,895
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,408 -0.4%
99.77
US$140,476 		1,408 -0.4% 99.77 US$140,476
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,699 -0.5%
98.54
US$167,419 		1,699 -0.5% 98.54 US$167,419
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
124 -0.1%
99.97
US$12,396 		124 -0.1% 99.97 US$12,396
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
7,434 -8.0%
99.29
US$738,122 		7,434 -8.0% 99.29 US$738,122
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
3,872 -4.0%
98.42
US$381,082 		3,872 -4.0% 98.42 US$381,082
2026-05-01 2026-04-30 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,082 -1.8%
99.57
US$107,735 		1,082 -1.8% 99.57 US$107,735
2026-05-01 2026-04-30 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
4,418 -6.8%
99.13
US$437,956 		4,418 -6.8% 99.13 US$437,956
2026-04-30 2026-04-30 PrS Proposed sale
2.6
DEBORAH MILLER

Officer

Officer
16,500
99.10
US$1,635,150 		16,500 99.10 US$1,635,150
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
300 -0.5%
101.17
US$30,351 		300 -0.5% 101.17 US$30,351
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
700 -1.2%
100.14
US$70,098 		700 -1.2% 100.14 US$70,098
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
4,500 -7.1%
99.35
US$447,075 		4,500 -7.1% 99.35 US$447,075
2026-04-13 2026-04-09 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
900 -1.4%
105.00
US$94,500 		900 -1.4% 105.00 US$94,500
2026-04-13 2026-04-09 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
2,193 -3.2%
104.27
US$228,664 		2,193 -3.2% 104.27 US$228,664
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
100 -0.0%
105.60
US$10,560 		100 -0.0% 105.60 US$10,560
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
6,121 -1.8%
104.78
US$641,358 		6,121 -1.8% 104.78 US$641,358
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
12,425 -3.6%
103.78
US$1,289,466 		12,425 -3.6% 103.78 US$1,289,466
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
11,354 -3.2%
103.21
US$1,171,846 		11,354 -3.2% 103.21 US$1,171,846
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,469 -2.8%
106.18
US$262,158 		2,469 -2.8% 106.18 US$262,158
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
5,417 -5.8%
105.30
US$570,410 		5,417 -5.8% 105.30 US$570,410
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
3,544 -3.7%
104.39
US$369,958 		3,544 -3.7% 104.39 US$369,958
2026-04-01 2026-03-30 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
2,968 -4.9%
98.13
US$291,250 		2,968 -4.9% 98.13 US$291,250
2026-04-01 2026-03-30 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
2,532 -4.0%
97.43
US$246,693 		2,532 -4.0% 97.43 US$246,693
2026-03-30 2026-03-30 PrS Proposed sale
2.3
Darlene Noci

Officer

Officer
22,000
96.66
US$2,126,520 		22,000 96.66 US$2,126,520
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
2,803 -4.5%
99.46
US$278,786 		2,803 -4.5% 99.46 US$278,786
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,757 -2.7%
98.21
US$172,555 		1,757 -2.7% 98.21 US$172,555
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
940 -1.4%
97.50
US$91,650 		940 -1.4% 97.50 US$91,650
2026-03-26 2026-03-25 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
13,700 -13.8%
100.16
US$1,372,192 		13,700 -13.8% 100.16 US$1,372,192
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,160 -1.2%
96.50
US$111,940 		1,160 -1.2% 96.50 US$111,940
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
7,671 -7.1%
95.88
US$735,495 		7,671 -7.1% 95.88 US$735,495
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,599 -2.3%
95.03
US$246,983 		2,599 -2.3% 95.03 US$246,983
2026-03-24 2026-03-24 PrS Proposed sale
2.3
Alexandra Balcom

Officer

Officer
59,420
96.43
US$5,729,870 		59,420 96.43 US$5,729,870
2026-03-16 2026-03-13 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
1,703 -2.5%
99.71
US$169,806 		1,703 -2.5% 99.71 US$169,806
2026-03-16 2026-03-13 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
2,597 -3.7%
98.83
US$256,662 		2,597 -3.7% 98.83 US$256,662
2026-03-16 2026-03-13 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
804 -1.1%
97.89
US$78,704 		804 -1.1% 97.89 US$78,704
2026-03-16 2026-03-12 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
306 -0.4%
99.12
US$30,331 		306 -0.4% 99.12 US$30,331
2026-03-16 2026-03-12 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
5,505 -7.2%
98.44
US$541,912 		5,505 -7.2% 98.44 US$541,912
2026-03-16 2026-03-12 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
24,189 -24.0%
97.79
US$2,365,442 		24,189 -24.0% 97.79 US$2,365,442
2026-03-12 2026-03-12 PrS Proposed sale
HENRY E PELISH

Officer

Officer
38,197
100.05
US$3,821,610 		38,197 100.05 US$3,821,610
2026-03-10 2026-03-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
400 -0.1%
100.19
US$40,076 		400 -0.1% 100.19 US$40,076
Explore more

More insider trading research around Nuvalent Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America